Next 10 |
2024-05-17 16:00:07 ET Jay Olson from Oppenheimer issued a price target of $380.00 for AMGN on 2024-05-17 14:37:00. The adjusted price target was set to $380.00. At the time of the announcement, AMGN was trading at $312.32. The overall price target consensus is at $277.3...
2024-05-17 14:40:17 ET More on Stocks Hasbro: Fairly Priced As Turnaround Game Plan Is Playing Out Tesla is reportedly considering data centers in China FAA operational hold on United Airlines remains intact - update Moderna vaccine patent upheld by European ...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER PR Newswire Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor IMDELLTRA Demonstrated Impressiv...
2024-05-16 15:40:44 ET More on Amgen Amgen Inc. (AMGN) BofA Securities 2024 Health Care Conference (Transcript) Amgen Could Become A Real Contender In The Obesity Market Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending CytomX ...
2024-05-16 06:48:39 ET More on Roche Roche: Value Remains Despite Covid-19 Revenue Growth Loss Roche Holding AG (RHHBY) Q1 2024 Sales/Trading Statement Call Transcript Q1 2024 Sales/ Trading Statement Call J&J, Roche, AstraZeneca poised to have highest or...
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024 PR Newswire THOUSAND OAKS, Calif. , May 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday , May 20, 2024 following the presentation o...
2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...
2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...
2024-05-14 16:43:02 ET Amgen Inc. (AMGN) BofA Securities 2024 Health Care Conference May 14, 2024 12:20 AM ET Company Participants Peter Griffith - EVP & CFO James Bradner - EVP, Research and Development & Chief Scientific Officer Justin Claeys - VP, IR ...
2024-05-13 04:06:09 ET Summary I have been focused on accumulating shares of blue chip compounders with market-beating returns and increasing passive income. I have reduced my holding count from 85 stocks/funds to 70 and have become more concentrated in my highest conviction ideas...
News, Short Squeeze, Breakout and More Instantly...
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
2024-05-17 16:00:07 ET Jay Olson from Oppenheimer issued a price target of $380.00 for AMGN on 2024-05-17 14:37:00. The adjusted price target was set to $380.00. At the time of the announcement, AMGN was trading at $312.32. The overall price target consensus is at $277.3...
Thursday, the FDA approved Amgen Inc’s (NASDAQ:AMGN) Imdelltra (tarlatamab-dlle) for the treatment of adult patients with exte...